Your browser doesn't support javascript.
loading
Analysis of Thermal Sensitivity of Human Cytomegalovirus Assayed in the Conventional Conditions of a Human Milk Bank.
Gayà, Antoni; Rittà, Massimo; Lembo, David; Tonetto, Paola; Cresi, Francesco; Sottemano, Stefano; Bertino, Enrico; Moro, Guido E; Calvo, Javier; Donalisio, Manuela.
Afiliação
  • Gayà A; Banc de Teixits, Fundació Banc de Sang i Teixits de les Illes Balears (FBSTIB), Palma, Spain.
  • Rittà M; Cell Therapy and Tissue Engineering Group (TERCIT), Balearic Islands Health Research Institute (IdISBa), Palma, Spain.
  • Lembo D; Laboratory of Molecular Virology and Antiviral Research, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
  • Tonetto P; Laboratory of Molecular Virology and Antiviral Research, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
  • Cresi F; Neonatal Care Unit of the University, City of Health and Science Hospital, Turin, Italy.
  • Sottemano S; Neonatal Care Unit of the University, City of Health and Science Hospital, Turin, Italy.
  • Bertino E; Neonatal Care Unit of the University, City of Health and Science Hospital, Turin, Italy.
  • Moro GE; Neonatal Care Unit of the University, City of Health and Science Hospital, Turin, Italy.
  • Calvo J; Italian Association of Human Milk Banks, Milan, Italy.
  • Donalisio M; Banc de Teixits, Fundació Banc de Sang i Teixits de les Illes Balears (FBSTIB), Palma, Spain.
Front Pediatr ; 9: 640638, 2021.
Article em En | MEDLINE | ID: mdl-34386465
One of the main concerns in human milk banks (HMB) is the transmission of human cytomegalovirus (HCMV) that could be present in the milk of infected women. There are consistent data showing that this virus is destroyed by Holder pasteurization (62.5°C for 30 min), but there is a lack of information about the response of the virus to the treatment at lower temperatures in strict HMB conditions. In order to analyze the effectiveness of different temperatures of pasteurization to eliminate HCMV in human milk, a preliminary assay was performed incubating HCMV-spiked raw milk samples from donor mothers at tested temperatures in a PCR thermocycler and the viral infectivity was assayed on cell cultures. No signs of viral replication were observed after treatments at temperatures equal or >53°C for 30, 20, and 10 min, 58°C for 5 min, 59°C for 2 min, and 60°C for 1 min. These data were confirmed in a pasteurizer-like model introducing HCMV-spiked milk in disposable baby bottles. No viral infectivity was detected on cell cultures after heating treatment of milk for 30 min at temperatures from 56 to 60°C. Thus, our results show that by using conventional pasteurization conditions, temperatures in the range of 56-60°C are enough to inactivate HCMV. Consequently, we consider that, in order to provide a higher quality product, the current recommendation to pasteurize both mother's own milk and donated milk at 62.5°C must be re-evaluated.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article